Amitriptyline/chlordiazepoxide, sold under the brand names Limbitrol and Limbitrol DS, is a combination of amitriptyline (Elavil), a tricyclic antidepressant, and chlordiazepoxide (Librium), a benzodiazepine, which is approved for the treatment of moderate to severe depression associated with moderate to severe anxiety in the United States.[1][2] It contains 12.5 to 25 mg amitriptyline and 5 to 10 mg chlordiazepoxide per tablet.[1][2]
 | |
 Amitriptyline (top) and chlordiazepoxide (bottom) | |
| Combination of | |
|---|---|
| Amitriptyline | Tricyclic antidepressant |
| Chlordiazepoxide | Benzodiazepine |
| Clinical data | |
| Trade names | Limbitrol, Limbitrol DS |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
References
edit- ^ a b Mylan Pharmaceuticals Inc. (May 2014). "Chlordiazepoxide and Amitriptyline Tablets Label" (PDF). U.S. Food and Drug Administration.
- ^ a b Townsend MC, Morgan KI (9 January 2018). Pocket Guide to Psychiatric Nursing. F.A. Davis. pp. 443–. ISBN 978-0-8036-7705-0. OCLC 1019871725.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |